Skip to content
Abierto
Menu

Award notice, first published as presolicitation

Emtricitabine/Tenofovir Disoproxil Fumarate Tablets Effective 10/06/2025-10/05/2026

36E79725R0035

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Avkare LLC

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of May 1, 2025.

N/A

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Avkare LLC
UEI
SFPGXE6XPS93
CAGE
4QGW8
Vendor location
Pulaski, TN
Contract
36E79725D0046
Obligated
$0.00, potential $9,977,968
Actions
4 between June 30, 2025 and September 1, 2026
Competition
Full and Open Competition, 3 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300MG Tablets with Avkare, Llc. Base Year Ordering Period Is October 6, 2025 to October 5, 2026 with Four ONE-YEAR Options.
Match
award number 36E79725D0046 equals the contract number; same awarding office 36E797 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. April 10, 2025

    Presolicitation

    Emtricitabine/Tenofovir Disoproxil Fumarate Tablets

    Due May 13, 2025 at 3:30 PM EDT. SAM.gov, notice 17a9e124e0384359aebac1cc0302787d

  2. May 1, 2025

    Solicitation, originally presolicitation

    Emtricitabine/Tenofovir Disoproxil Fumarate Tablets

    Due May 16, 2025 at 3:30 PM EDT. SAM.gov, notice 674fef5d93f14b2f93c304ef0ee1781d

  3. June 30, 2025

    Award notice, originally solicitation

    Awarded to Avkare LLC Pulaski 38478 for $9,977,968. SAM.gov, notice 48c5f71a1ea74882aa1b7d272bf626ea

Points of contact

Also open from this buyer